On January 9, 2020 CSL Limited, parent company of biotherapeutics leader CSL Behring and world-leading influenza provider Seqirus, reported that it will present at the 38th annual J.P. Morgan Healthcare Conference in San Francisco (Press release, CSL, JAN 9, 2020, View Source [SID1234552949]). Chief Executive Officer and Managing Director Paul Perreault will present the company’s overview on Monday, January 13, at 3:30 p.m. PT, (6:30 p.m. ET), at the Westin St. Francis Hotel.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!